Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Verderio

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapyG Gasparini, P Bevilacqua, E Bonoldi, et al.
The Cancer Journal From Scientific American|July 1, 1995
Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapyG Gasparini, M Barbareschi, P Boracchi, et al.
Breast Cancer Research and Treatment|January 1, 1995
Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric studyP Bevilacqua, M Barbareschi, P Verderio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patientsG Gasparini, S B Fox, P Verderio, et al.
British Journal of Cancer|April 7, 1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implicationsS Viviani, E Camerini, V Bonfante, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancerG Gasparini, M Barbareschi, C Doglioni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 9, 2014
Influence of pre-analytical procedures on genomic DNA integrity in blood samples: the SPIDIA experienceF Malentacchi, C M Ciniselli, M Pazzagli, et al.
British Journal of Cancer|July 4, 1998
Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-upF A Mauri, O Caffo, S Veronese, et al.
International Journal of Cancer|June 21, 1996
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomasG Gasparini, E Bonoldi, G Viale, et al.
British Journal of Cancer|January 16, 2014
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancerS Zanutto, S Pizzamiglio, M Ghilotti, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapyG Gasparini, P Bevilacqua, E Bonoldi, et al.
The Cancer Journal From Scientific American|July 1, 1995
Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapyG Gasparini, M Barbareschi, P Boracchi, et al.
Breast Cancer Research and Treatment|January 1, 1995
Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric studyP Bevilacqua, M Barbareschi, P Verderio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patientsG Gasparini, S B Fox, P Verderio, et al.
British Journal of Cancer|April 7, 1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implicationsS Viviani, E Camerini, V Bonfante, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancerG Gasparini, M Barbareschi, C Doglioni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 9, 2014
Influence of pre-analytical procedures on genomic DNA integrity in blood samples: the SPIDIA experienceF Malentacchi, C M Ciniselli, M Pazzagli, et al.
British Journal of Cancer|July 4, 1998
Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-upF A Mauri, O Caffo, S Veronese, et al.
International Journal of Cancer|June 21, 1996
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomasG Gasparini, E Bonoldi, G Viale, et al.
British Journal of Cancer|January 16, 2014
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancerS Zanutto, S Pizzamiglio, M Ghilotti, et al.
Pageof 5